Victor Montosa-I-Micó

Victor Montosa-I-Micó

Auto-generated profile, based on publicly available information

Victor Montosa-I-Micó

Instituto de Aplicaciones de las Tecnologias de la Informacion y de las Comunicaciones Avanzadas (ITACA), Universitat Politecnica de Valencia, Valencia, Spain.

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 February 2026 in Neuro-Oncology
Verified
Journal Article
Open access
MGMaria Gómez-Mahiques
Maria Gómez-Mahiques
CLCarles Lopez-Mateu
Carles Lopez-Mateu
FGF Javier Gil-Terrón
F Javier Gil-Terrón
VMVictor Montosa-I-Micó
Victor Montosa-I-Micó
SSSiri Fløgstad Svensson
Siri Fløgstad Svensson
EFElies Fuster-Garcia
Elies Fuster-Garcia
Background: Precise delineation of non-contrast-enhancing tumor (nCET) in glioblastoma (GB) is critical for maximal safe resection, yet routine imaging cannot reliably separate infiltrative tumor from vasogenic edema. The aim of this study was to develop and validate an automated method to identify peritumoral subregions compatible with nCET and assess its prognostic value. Methods: Pre-operative T2-weighted and FLAIR MRI from 940 patients with newly diagnosed GB in four multicenter cohorts were analyzed. A deep-learning model segmented enhancing tumor, edema and necrosis; a non-local, spatially varying finite mixture model was applied to identify edema subregions characterized by relatively lower FLAIR hyperintensity, hypothesized to reflect nCET-related tissue. The ratio of these subregions to total edema volume defined the T2/FLAIR Heterogeneity Index (TFHI). Associations between TFHI and overall survival (OS) were examined with Kaplan–Meier curves and multivariable Cox regression. Results: Higher TFHI values stratified patients with shorter OS. In the NCT03439332, TFHI above the optimal threshold was associated with a twofold increased hazard of death (hazard ratio [HR] 2.07, 95 % confidence interval 1.33-3.21; P = .0013) and a reduction in median survival of 98 days. Significant, though smaller, prognostic effects were confirmed in GLIOCAT & BraTS (HR= 1.37; P = .047), OUS (HR = 1.37; P = .0032) and pooled analysis (HR= 1.26; P = .0008). TFHI remained an independent predictor after adjustment for age, extent of resection and MGMT methylation. Conclusions: We present a reproducible, server-hosted tool for automated identification of imaging-defined, putative nCET-related peritumoral subregions and TFHI biomarker extraction that enables independent prognostic stratification. This approach provides a quantitative framework for studying peritumoral heterogeneity in GB.

17 May 2024 in Heliyon
Verified
Journal Article
Open access
VMVíctor Montosa-I-Micó
Víctor Montosa-I-Micó
MÁMaría del Mar Álvarez-Torres
María del Mar Álvarez-Torres
RBRebeca Burgos-Panadero
Rebeca Burgos-Panadero
FGF. Javier Gil-Terrón
F. Javier Gil-Terrón
MMMaria Gómez Mahiques
Maria Gómez Mahiques
EFElies Fuster-Garcia
Elies Fuster-Garcia
The vascular heterogeneity of glioblastomas (GB) remains an important area of research, since tumor progression and patient prognosis are closely tied to this feature. With this study, we aim to identify gene expression profiles associated with MRI-defined tumor vascularity and to investigate its relationship with patient prognosis. The study employed MRI parameters calculated with DSC Perfusion Quantification of ONCOhabitats glioma analysis software and RNA-seq data from the TCGA-GBM project dataset. In our study, we had a total of 147 RNA-seq samples, which 15 of them also had MRI parameter information. We analyzed the gene expression profiles associated with MRI-defined tumor vascularity using differential gene expression analysis and performed Log-rank tests to assess the correlation between the identified genes and patient prognosis. The findings of our research reveal a set of 21 overexpressed genes associated with the high vascularity pattern. Notably, several of these overexpressed genes have been previously implicated in worse prognosis based on existing literature. Our log-rank test further validates that the collective upregulation of these genes is indeed correlated with an unfavorable prognosis. This set of genes includes a variety of molecules, such as cytokines, receptors, ligands, and other molecules with diverse functions. Our findings suggest that the set of 21 overexpressed genes in the High Vascularity group could potentially serve as prognostic markers for GB patients. These results highlight the importance of further investigating the relationship between the molecules such as cytokines or receptors underlying the vascularity in GB and its observation through MRI and developing targeted therapies for this aggressive disease.

28 June 2025 in medRxiv
Verified
Preprint
Open access
PDF file
MGMaria Gómez-Mahiques
Maria Gómez-Mahiques
CLCarles Lopez-Mateu
Carles Lopez-Mateu
FGF. Javier Gil-Terrón
F. Javier Gil-Terrón
VMVictor Montosa-I-Micó
Victor Montosa-I-Micó
SSSiri Fløgstad Svensson
Siri Fløgstad Svensson
EFElies Fuster-Garcia
Elies Fuster-Garcia
Background: Precise delineation of non-contrast-enhancing tumor (nCET) in glioblastoma (GB) is critical for maximal safe resection, yet routine imaging cannot reliably separate infiltrative tumor from vasogenic edema. The aim of this study was to develop and validate an automated method to identify nCET and assess its prognostic value. Methods: Pre-operative T2-weighted and FLAIR MRI from 940 patients with newly diagnosed GB in four multicenter cohorts were analyzed. A deep-learning model segmented enhancing tumor, edema and necrosis; a non-local spatially varying finite mixture model then isolated edema subregions containing nCET. The ratio of nCET to total edema volume—the Diffuse Infiltration Index (DII)—was calculated. Associations between DII and overall survival (OS) were examined with Kaplan–Meier curves and multivariable Cox regression. Results: The algorithm distinguished nCET from vasogenic edema in 97.5 % of patients, showing a mean signal-intensity gap > 5 %. Higher DII is able to stratify patients with shorter OS. In the NCT03439332 cohort, DII above the optimal threshold doubled the hazard of death (hazard ratio 2.09, 95 % confidence interval 1.34–3.25; p = 0.0012) and reduced median survival by 122 days. Significant, though smaller, effects were confirmed in GLIOCAT & BraTS (hazard ratio 1.31; p = 0.022), OUS (hazard ratio 1.28; p = 0.007) and in pooled analysis (hazard ratio 1.28; p = 0.0003). DII remained an independent predictor after adjustment for age, extent of resection and MGMT methylation. Conclusions: We present a reproducible, server-hosted tool for automated nCET delineation and DII biomarker extraction that enables robust, independent prognostic stratification. It promises to guide supramaximal surgical planning and personalized neuro-oncology research and care. Key Points: ‐ KP1: Robust automated MRI tool segments non-contrast-enhancing (nCET) glioblastoma. ‐ KP2: Introduced and validated the Diffuse Infiltration Index with prognostic value. ‐ KP3: nCET mapping enables RANO supramaximal resection for personalized surgery. Importance of the Study: This study underscores the clinical importance of accurately delineating non-contrast-enhancing tumor (nCET) regions in glioblastoma (GB) using standard MRI. Despite their lack of contrast enhancement, nCET areas often harbor infiltrative tumor cells critical for disease progression and recurrence. By integrating deep learning segmentation with a non-local finite mixture model, we developed a reproducible, automated methodology for nCET delineation and introduced the Diffuse Infiltration Index (DII), a novel imaging biomarker. Higher DII values were independently associated with reduced overall survival across large, heterogeneous cohorts. These findings highlight the prognostic relevance of imaging-defined infiltration patterns and support the use of nCET segmentation in clinical decision-making. Importantly, this methodology aligns with and operationalizes recent RANO criteria on supramaximal resection, offering a practical, image-based tool to improve surgical planning. In doing so, our work advances efforts toward more personalized neuro-oncological care, potentially improving outcomes while minimizing functional compromise.

25 November 2025 in BMC Health Services Research
Verified
Journal Article
Open access
PDF file
VMVíctor Montosa-I-Micó
Víctor Montosa-I-Micó
CTCecilia Tortajada
Cecilia Tortajada
ÁBÁlvaro Navarro Batet
Álvaro Navarro Batet
RCRaquel Alcalde Castillo
Raquel Alcalde Castillo
MCMiguel Camacho
Miguel Camacho
JGJuan M. García-Gómez
Juan M. García-Gómez
The management of HIV patients is inherently complex, requiring the integration of evolving clinical guidelines such as GESIDA 2023. These guidelines are e

28 July 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
RBRebeca Burgos-Panadero
Rebeca Burgos-Panadero
MSMaría Rosado Sanz
María Rosado Sanz
VMVictor Montosa-I-Mico
Victor Montosa-I-Mico
ZTZoey J Tolboom
Zoey J Tolboom
NANuria Martinez Alarcon
Nuria Martinez Alarcon
JMJaime Font de Mora
Jaime Font de Mora
Background: Glioblastoma (GBM) is a highly heterogeneous and vascularized malignancy in which the mesenchymal (MES) subtype is associated with poor prognosis, extensive macrophage infiltration and resistance to therapy. However, the signaling mechanisms integrating vascular remodeling with inflammatory tumor-macrophage crosstalk remain incompletely understood. Methods: We integrated magnetic resonance imaging-derived vascular phenotyping with transcriptomic analyses of human glioblastoma cohorts to identify molecular pathways associated with highly vascular tumors. Functional studies using glioblastoma cell lines, THP-1-derived macrophages and co-culture systems were performed to investigate the role of PI3K signaling in tumor-macrophage communication. Finally, an independent single-cell transcriptomic cohort of primary human glioblastoma was interrogated to determine whether the identified inflammatory programs were conserved in malignant cells from patient tumors. Results: Integrated imaging-transcriptomic analyses identified highly vascular glioblastomas as tumors enriched for the MES subtype, increased macrophage infiltration and activation of PI3K-associated signaling. Pharmacological inhibition of PI3K reduced the expression of macrophage-recruiting cytokines and impaired the ability of glioblastoma cells to educate macrophages toward an immunosuppressive phenotype. Reciprocally, tumor-educated macrophages enhanced inflammatory signaling, immune checkpoint expression and migratory capacity in glioblastoma cells, whereas IL-6 blockade attenuated these effects, identifying IL-6 as a key mediator of this bidirectional communication. To determine whether these inflammatory programs were conserved in human disease, we analyzed an independent single-cell transcriptomic dataset of primary glioblastomas. MES-like malignant cells exhibited the strongest inflammatory transcriptional programs among the four malignant transcriptional states, including higher NF-κB activation program scores and tumor-macrophage communication signature scores. At the tumor level, MES-like enrichment was positively associated with higher inflammatory program activity, supporting the clinical relevance of the proposed signaling axis. Conclusions: Together, our findings identify PI3K signaling as a central regulator integrating vascular remodeling with inflammatory tumor-macrophage communication in mesenchymal glioblastoma. These results provide a mechanistic framework linking PI3K signaling, macrophage education and the MES phenotype, and provide a rationale for therapeutic strategies aimed at disrupting inflammatory signaling within the glioblastoma microenvironment.